Abstract
Obesity is a major health problem, contributing to the development of various diseases with aging. In humans, obesity has been associated with reduced testosterone production and subfertility. Adipose tissue is an important source of hormones having influences on both metabolism and reproduction. Among them, the production and secretion of adiponectin is inversely correlated to the severity of obesity. The purpose of this review of literature is to present the current state of knowledge on adiponectin research to determine whether this hormone affects reproduction in men. Surprisingly, evidences show negative influences of adiponectin on GnRH secretion from the hypothalamus, LH and FSH secretion from the pituitary and testosterone at the testicular level. Thus far, the involvement of adiponectin in the influence of metabolism on reproduction in men is limited. However, adiponectin and its receptors are expressed by different cell types of the male gonad, including Leydig cells, spermatozoa, and epididymis. In addition, actions of adiponectin at the testicular level have been shown to promote spermatogenesis and sperm maturation. Therefore, autocrine/paracrine actions of adiponectin in the testis may contribute to support male reproductive function.
Similar content being viewed by others
References
F.X. Pi-Sunyer, The obesity epidemic: pathophysiology and consequences of obesity. Obes. Res. 10(Suppl 2), 97S–104S (2002)
K.M. Flegal, M.D. Carroll, B.K. Kit, C.L. Ogden, Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. J. Am. Med. Assoc. 307, 491–497 (2012)
C.A. Derby, S. Zilber, D. Brambilla, K.H. Morales, J.B. McKinlay, Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: the Massachusetts Male Ageing Study. Clin. Endocrinol. (Oxf.) 65, 125–131 (2006)
R.S. Tan, S.J. Pu, Impact of obesity on hypogonadism in the andropause. Int. J. Androl. 25, 195–201 (2002)
P.M. Mah, G.A. Wittert, Obesity and testicular function. Mol. Cell. Endocrinol. 316, 180–186 (2010)
D. Landry, F. Cloutier, L.J. Martin, Implications of leptin in neuroendocrine regulation of male reproduction. Reprod. Biol. 13, 1–14 (2013)
M. Pardo, A. Roca-Rivada, L.M. Seoane, F.F. Casanueva, Obesidomics: contribution of adipose tissue secretome analysis to obesity research. Endocrine 41, 374–383 (2012)
K. Marinou, D. Tousoulis, A.S. Antonopoulos, E. Stefanadi, C. Stefanadis, Obesity and cardiovascular disease: from pathophysiology to risk stratification. Int. J. Cardiol. 138, 3–8 (2010)
K. Rabe, M. Lehrke, K.G. Parhofer, U.C. Broedl, Adipokines and insulin resistance. Mol. Med. Camb. Mass. 14, 741–751 (2008)
P.G. Cohen, Aromatase, adiposity, aging and disease. The hypogonadal–metabolic–atherogenic-disease and aging connection. Med. Hypotheses 56, 702–708 (2001)
A. Vermeulen, Decreased androgen levels and obesity in men. Ann. Med. 28, 13–15 (1996)
A. Vermeulen, J.M. Kaufman, Ageing of the hypothalamo–pituitary–testicular axis in men. Horm. Res. 43, 25–28 (1995)
G. Schneider, M.A. Kirschner, R. Berkowitz, N.H. Ertel, Increased estrogen production in obese men. J. Clin. Endocrinol. Metab. 48, 633–638 (1979)
A.M. Corbould, S.J. Judd, R.J. Rodgers, Expression of types 1, 2, and 3 17 beta-hydroxysteroid dehydrogenase in subcutaneous abdominal and intra-abdominal adipose tissue of women. J. Clin. Endocrinol. Metab. 83, 187–194 (1998)
P. Mårin, S. Arver, Androgens and abdominal obesity. Baillières Clin. Endocrinol. Metab. 12, 441–451 (1998)
P. Mårin, Testosterone and regional fat distribution. Obes. Res. 3(Suppl 4), 609S–612S (1995)
R. Lazarus, D. Sparrow, S. Weiss, Temporal relations between obesity and insulin: longitudinal data from the normative aging study. Am. J. Epidemiol. 147, 173–179 (1998)
D. Goodman-Gruen, E. Barrett-Connor, Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women. Diabetes Care 23, 912–918 (2000)
E.C. Tsai, E.J. Boyko, D.L. Leonetti, W.Y. Fujimoto, Low serum testosterone level as a predictor of increased visceral fat in Japanese-American men. Int. J. Obes. Relat. Metab. Disord. 24, 485–491 (2000)
V.A. Giagulli, J.M. Kaufman, A. Vermeulen, Pathogenesis of the decreased androgen levels in obese men. J. Clin. Endocrinol. Metab. 79, 997–1000 (1994)
P.G. Cohen, The hypogonadal-obesity cycle: role of aromatase in modulating the testosterone–estradiol shunt: a major factor in the genesis of morbid obesity. Med. Hypotheses 52, 49–51 (1999)
H.K. Kley, H.G. Solbach, J.C. McKinnan, H.L. Krüskemper, Testosterone decrease and oestrogen increase in male patients with obesity. Acta Endocrinol. (Cph.) 91, 553–563 (1979)
B. Zumoff, G.W. Strain, L.K. Miller, W. Rosner, R. Senie, D.S. Seres, R.S. Rosenfeld, Plasma free and non-sex-hormone-binding-globulin-bound testosterone are decreased in obese men in proportion to their degree of obesity. J. Clin. Endocrinol. Metab. 71, 929–931 (1990)
T. Kadowaki, T. Yamauchi, Adiponectin and adiponectin receptors. Endocr. Rev. 26, 439–451 (2005)
J. Hoffstedt, E. Arvidsson, E. Sjölin, K. Wåhlén, P. Arner, Adipose tissue adiponectin production and adiponectin serum concentration in human obesity and insulin resistance. J. Clin. Endocrinol. Metab. 89, 1391–1396 (2004)
K. Hotta, T. Funahashi, Y. Arita, M. Takahashi, M. Matsuda, Y. Okamoto, H. Iwahashi, H. Kuriyama, N. Ouchi, K. Maeda, M. Nishida, S. Kihara, N. Sakai, T. Nakajima, K. Hasegawa, M. Muraguchi, Y. Ohmoto, T. Nakamura, S. Yamashita, T. Hanafusa, Y. Matsuzawa, Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 20, 1595–1599 (2000)
I.J. Neeland, C.R. Ayers, A.K. Rohatgi, A.T. Turer, J.D. Berry, S.R. Das, G.L. Vega, A. Khera, D.K. McGuire, S.M. Grundy, J.A. de Lemos, Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults. Obes. Silver Spring Md. 21, E439–E447 (2013)
Y. Arita, S. Kihara, N. Ouchi, M. Takahashi, K. Maeda, J. Miyagawa, K. Hotta, I. Shimomura, T. Nakamura, K. Miyaoka, H. Kuriyama, M. Nishida, S. Yamashita, K. Okubo, K. Matsubara, M. Muraguchi, Y. Ohmoto, T. Funahashi, Y. Matsuzawa, Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257, 79–83 (1999)
M. Cnop, P.J. Havel, K.M. Utzschneider, D.B. Carr, M.K. Sinha, E.J. Boyko, B.M. Retzlaff, R.H. Knopp, J.D. Brunzell, S.E. Kahn, Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46, 459–469 (2003)
F.B. Diamond Jr, D. Cuthbertson, S. Hanna, D. Eichler, Correlates of adiponectin and the leptin/adiponectin ratio in obese and non-obese children. J. Pediatr. Endocrinol. Metab. 17, 1069–1075 (2004)
M. Bulló, J. Salas-Salvadó, P. García-Lorda, Adiponectin expression and adipose tissue lipolytic activity in lean and obese women. Obes. Surg. 15, 382–386 (2005)
S.K. Jacobi, K.M. Ajuwon, T.E. Weber, J.L. Kuske, C.J. Dyer, M.E. Spurlock, Cloning and expression of porcine adiponectin, and its relationship to adiposity, lipogenesis and the acute phase response. J. Endocrinol. 182, 133–144 (2004)
T. Yamauchi, J. Kamon, H. Waki, Y. Terauchi, N. Kubota, K. Hara, Y. Mori, T. Ide, K. Murakami, N. Tsuboyama-Kasaoka, O. Ezaki, Y. Akanuma, O. Gavrilova, C. Vinson, M.L. Reitman, H. Kagechika, K. Shudo, M. Yoda, Y. Nakano, K. Tobe, R. Nagai, S. Kimura, M. Tomita, P. Froguel, T. Kadowaki, The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7, 941–946 (2001)
E. Hu, P. Liang, B.M. Spiegelman, AdipoQ is a novel adipose-specific gene dysregulated in obesity. J. Biol. Chem. 271, 10697–10703 (1996)
Kadowaki, T., Yamauchi, T., Kubota, N., Hara, K., Ueki, K.: Adiponectin and adiponectin receptors in obesity-linked insulin resistance. Novartis Found. Symp. 286, 164–176 (2007); discussion 176–182, 200–203
C. Weyer, T. Funahashi, S. Tanaka, K. Hotta, Y. Matsuzawa, R.E. Pratley, P.A. Tataranni, Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 86, 1930–1935 (2001)
B. Antuna-Puente, B. Feve, S. Fellahi, J.-P. Bastard, Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab. 34, 2–11 (2008)
L. Sieminska, B. Marek, B. Kos-Kudla, D. Niedziolka, D. Kajdaniuk, M. Nowak, J. Glogowska-Szelag, Serum adiponectin in women with polycystic ovarian syndrome and its relation to clinical, metabolic and endocrine parameters. J. Endocrinol. Invest. 27, 528–534 (2004)
Y. Okamoto, Adiponectin provides cardiovascular protection in metabolic syndrome. Cardiol. Res. Pract. 2011, 313179 (2011)
H.-S. Kim, J. Jo, J.E. Lim, Y.D. Yun, S.J. Baek, T.-Y. Lee, K.B. Huh, S.H. Jee, Adiponectin as predictor for diabetes among pre-diabetic groups. Endocrine 44, 411–418 (2013)
J. Bai, Y. Liu, G.-F. Niu, L.-X. Bai, X.-Y. Xu, G.-Z. Zhang, L.-X. Wang, Relationship between adiponectin and testosterone in patients with type 2 diabetes. Biochem. Medica Časopis Hrvat. Društva Med. Biokem. HDMB 21, 65–70 (2011)
P.E. Scherer, S. Williams, M. Fogliano, G. Baldini, H.F. Lodish, A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 270, 26746–26749 (1995)
L. Shapiro, P.E. Scherer, The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Curr. Biol. 8, 335–338 (1998)
Y. Wang, K.S.L. Lam, M. Yau, A. Xu, Post-translational modifications of adiponectin: mechanisms and functional implications. Biochem. J. 409, 623–633 (2008)
F. Simpson, J.P. Whitehead, Adiponectin: it’s all about the modifications. Int. J. Biochem. Cell Biol. 42, 785–788 (2010)
Y. Wang, A. Xu, C. Knight, L.Y. Xu, G.J.S. Cooper, Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin. Potential role in the modulation of its insulin-sensitizing activity. J. Biol. Chem. 277, 19521–19529 (2002)
Y. Wang, K.S.L. Lam, L. Chan, K.W. Chan, J.B.B. Lam, M.C. Lam, R.C.L. Hoo, W.W.N. Mak, G.J.S. Cooper, A. Xu, Post-translational modifications of the four conserved lysine residues within the collagenous domain of adiponectin are required for the formation of its high molecular weight oligomeric complex. J. Biol. Chem. 281, 16391–16400 (2006)
A.A. Richards, T. Stephens, H.K. Charlton, A. Jones, G.A. Macdonald, J.B. Prins, J.P. Whitehead, Adiponectin multimerization is dependent on conserved lysines in the collagenous domain: evidence for regulation of multimerization by alterations in posttranslational modifications. Mol. Endocrinol. Baltim. Md. 20, 1673–1687 (2006)
T.-S. Tsao, E. Tomas, H.E. Murrey, C. Hug, D.H. Lee, N.B. Ruderman, J.E. Heuser, H.F. Lodish, Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways. J. Biol. Chem. 278, 50810–50817 (2003)
R. Basu, U.B. Pajvani, R.A. Rizza, P.E. Scherer, Selective downregulation of the high molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects. Diabetes 56, 2174–2177 (2007)
U.B. Pajvani, M. Hawkins, T.P. Combs, M.W. Rajala, T. Doebber, J.P. Berger, J.A. Wagner, M. Wu, A. Knopps, A.H. Xiang, K.M. Utzschneider, S.E. Kahn, J.M. Olefsky, T.A. Buchanan, P.E. Scherer, Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J. Biol. Chem. 279, 12152–12162 (2004)
H. Waki, T. Yamauchi, J. Kamon, Y. Ito, S. Uchida, S. Kita, K. Hara, Y. Hada, F. Vasseur, P. Froguel, S. Kimura, R. Nagai, T. Kadowaki, Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J. Biol. Chem. 278, 40352–40363 (2003)
R.B. Ceddia, R. Somwar, A. Maida, X. Fang, G. Bikopoulos, G. Sweeney, Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells. Diabetologia 48, 132–139 (2005)
X. Fang, R. Palanivel, X. Zhou, Y. Liu, A. Xu, Y. Wang, G. Sweeney, Hyperglycemia- and hyperinsulinemia-induced alteration of adiponectin receptor expression and adiponectin effects in L6 myoblasts. J. Mol. Endocrinol. 35, 465–476 (2005)
E. Tomas, T.-S. Tsao, A.K. Saha, H.E. Murrey, Cc. Zhang, C. cheng, S.I. Itani, H.F. Lodish, N.B. Ruderman, Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc. Natl Acad. Sci. USA 99, 16309–16313 (2002)
J. Fruebis, T.S. Tsao, S. Javorschi, D. Ebbets-Reed, M.R. Erickson, F.T. Yen, B.E. Bihain, H.F. Lodish, Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl Acad. Sci. USA 98, 2005–2010 (2001)
U.B. Pajvani, X. Du, T.P. Combs, A.H. Berg, M.W. Rajala, T. Schulthess, J. Engel, M. Brownlee, P.E. Scherer, Structure–function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. J. Biol. Chem. 278, 9073–9085 (2003)
H. Waki, T. Yamauchi, J. Kamon, S. Kita, Y. Ito, Y. Hada, S. Uchida, A. Tsuchida, S. Takekawa, T. Kadowaki, Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1. Endocrinology 146, 790–796 (2005)
C. Chabrolle, L. Tosca, J. Dupont, Regulation of adiponectin and its receptors in rat ovary by human chorionic gonadotrophin treatment and potential involvement of adiponectin in granulosa cell steroidogenesis. Reprod. Camb. Engl. 133, 719–731 (2007)
Z.V. Wang, P.E. Scherer, Adiponectin, cardiovascular function, and hypertension. Hypertension 51, 8–14 (2008)
Luque-Ramírez, M., Martínez-García, M.Á., Montes-Nieto, R., Fernández-Durán, E., Insenser, M., Alpañés, M., Escobar-Morreale, H.F.: Sexual dimorphism in adipose tissue function as evidenced by circulating adipokine concentrations in the fasting state and after an oral glucose challenge. Hum. Reprod. Oxf. Engl. 28, 1908–1918 (2013)
T.P. Combs, A.H. Berg, M.W. Rajala, S. Klebanov, P. Iyengar, J.C. Jimenez-Chillaron, M.E. Patti, S.L. Klein, R.S. Weinstein, P.E. Scherer, Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 52, 268–276 (2003)
K. Robinson, J. Prins, B. Venkatesh, Clinical review: adiponectin biology and its role in inflammation and critical illness. Crit. Care Lond. Engl. 15, 221 (2011)
K. Brochu-Gaudreau, C. Rehfeldt, R. Blouin, V. Bordignon, B.D. Murphy, M.-F. Palin, Adiponectin action from head to toe. Endocrine 37, 11–32 (2010)
M. Calvani, A. Scarfone, L. Granato, E.V. Mora, G. Nanni, M. Castagneto, A.V. Greco, M. Manco, G. Mingrone, Restoration of adiponectin pulsatility in severely obese subjects after weight loss. Diabetes 53, 939–947 (2004)
L. Fajas, J.C. Fruchart, J. Auwerx, Transcriptional control of adipogenesis. Curr. Opin. Cell Biol. 10, 165–173 (1998)
T.F. Osborne, Sterol regulatory element-binding proteins (SREBPs): key regulators of nutritional homeostasis and insulin action. J. Biol. Chem. 275, 32379–32382 (2000)
M.I. Yilmaz, A. Sonmez, K. Caglar, D.E. Gok, T. Eyileten, M. Yenicesu, C. Acikel, N. Bingol, S. Kilic, Y. Oguz, A. Vural, Peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonist increases plasma adiponectin levels in type 2 diabetic patients with proteinuria. Endocrine 25, 207–214 (2004)
A.C. Doran, N. Meller, A. Cutchins, H. Deliri, R.P. Slayton, S.N. Oldham, J.B. Kim, S.R. Keller, C.A. McNamara, The helix–loop–helix factors Id3 and E47 are novel regulators of adiponectin. Circ. Res. 103, 624–634 (2008)
N. Maeda, M. Takahashi, T. Funahashi, S. Kihara, H. Nishizawa, K. Kishida, H. Nagaretani, M. Matsuda, R. Komuro, N. Ouchi, H. Kuriyama, K. Hotta, T. Nakamura, I. Shimomura, Y. Matsuzawa, PPAR gamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50, 2094–2099 (2001)
M. Iwaki, M. Matsuda, N. Maeda, T. Funahashi, Y. Matsuzawa, M. Makishima, I. Shimomura, Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 52, 1655–1663 (2003)
K. Thomas, D.-Y. Sung, X. Chen, W. Thompson, Y.E. Chen, J. McCarrey, W. Walker, M. Griswold, Developmental patterns of PPAR and RXR gene expression during spermatogenesis. Front. Biosci. Elite Ed. 3, 1209–1220 (2011)
M.P. Kowalewski, M.T. Dyson, P.R. Manna, D.M. Stocco, Involvement of peroxisome proliferator-activated receptor gamma in gonadal steroidogenesis and steroidogenic acute regulatory protein expression. Reprod. Fertil. Dev. 21, 909–922 (2009)
B. El-Asmar, X.C. Giner, J.J. Tremblay, Transcriptional cooperation between NF-kappaB p50 and CCAAT/enhancer binding protein beta regulates Nur77 transcription in Leydig cells. J. Mol. Endocrinol. 42, 131–138 (2009)
L.M. Grønning, M.K. Dahle, K.A. Taskén, S. Enerbäck, L. Hedin, K. Taskén, H.K. Knutsen, Isoform-specific regulation of the CCAAT/enhancer-binding protein family of transcription factors by 3′,5′-cyclic adenosine monophosphate in Sertoli cells. Endocrinology 140, 835–843 (1999)
H. Wang, F. Liu, C.F. Millette, D.L. Kilpatrick, Expression of a novel, sterol-insensitive form of sterol regulatory element binding protein 2 (SREBP2) in male germ cells suggests important cell- and stage-specific functions for SREBP targets during spermatogenesis. Mol. Cell. Biol. 22, 8478–8490 (2002)
M. Carroll, B. Robaire, Null mutation of the transcription factor inhibitor of DNA binding 3 (ID3) in male mice adversely impacts on fertility and reproductive outcome. J. Androl. 33, 667–674 (2012)
J. Chaudhary, J. Johnson, G. Kim, M.K. Skinner, Hormonal regulation and differential actions of the helix–loop–helix transcriptional inhibitors of differentiation (Id1, Id2, Id3, and Id4) in Sertoli cells. Endocrinology 142, 1727–1736 (2001)
J. Chaudhary, M.K. Skinner, The basic helix–loop–helix E2A gene product E47, not E12, is present in differentiating Sertoli cells. Mol. Reprod. Dev. 52, 1–8 (1999)
T. Yamauchi, J. Kamon, Y. Ito, A. Tsuchida, T. Yokomizo, S. Kita, T. Sugiyama, M. Miyagishi, K. Hara, M. Tsunoda, K. Murakami, T. Ohteki, S. Uchida, S. Takekawa, H. Waki, N.H. Tsuno, Y. Shibata, Y. Terauchi, P. Froguel, K. Tobe, S. Koyasu, K. Taira, T. Kitamura, T. Shimizu, R. Nagai, T. Kadowaki, Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423, 762–769 (2003)
T. Yamauchi, Y. Nio, T. Maki, M. Kobayashi, T. Takazawa, M. Iwabu, M. Okada-Iwabu, S. Kawamoto, N. Kubota, T. Kubota, Y. Ito, J. Kamon, A. Tsuchida, K. Kumagai, H. Kozono, Y. Hada, H. Ogata, K. Tokuyama, M. Tsunoda, T. Ide, K. Murakami, M. Awazawa, I. Takamoto, P. Froguel, K. Hara, K. Tobe, R. Nagai, K. Ueki, T. Kadowaki, Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat. Med. 13, 332–339 (2007)
M. Bjursell, A. Ahnmark, M. Bohlooly-Y, L. William-Olsson, M. Rhedin, X.-R. Peng, K. Ploj, A.-K. Gerdin, G. Arnerup, A. Elmgren, A.-L. Berg, J. Oscarsson, D. Lindén, Opposing effects of adiponectin receptors 1 and 2 on energy metabolism. Diabetes 56, 583–593 (2007)
K. Kos, A.L. Harte, N.F. da Silva, A. Tonchev, G. Chaldakov, S. James, D.R. Snead, B. Hoggart, J.P. O’Hare, P.G. McTernan, S. Kumar, Adiponectin and resistin in human cerebrospinal fluid and expression of adiponectin receptors in the human hypothalamus. J. Clin. Endocrinol. Metab. 92, 1129–1136 (2007)
F. Rodriguez-Pacheco, A.J. Martinez-Fuentes, S. Tovar, L. Pinilla, M. Tena-Sempere, C. Dieguez, J.P. Castaño, M.M. Malagon, Regulation of pituitary cell function by adiponectin. Endocrinology 148, 401–410 (2007)
J.E. Caminos, R. Nogueiras, F. Gaytán, R. Pineda, C.R. González, M.L. Barreiro, J.P. Castaño, M.M. Malagón, L. Pinilla, J. Toppari, C. Diéguez, M. Tena-Sempere, Novel expression and direct effects of adiponectin in the rat testis. Endocrinology 149, 3390–3402 (2008)
E. Lord, S. Ledoux, B.D. Murphy, D. Beaudry, M.F. Palin, Expression of adiponectin and its receptors in swine. J. Anim. Sci. 83, 565–578 (2005)
S. Ledoux, D.B. Campos, F.L. Lopes, M. Dobias-Goff, M.-F. Palin, B.D. Murphy, Adiponectin induces periovulatory changes in ovarian follicular cells. Endocrinology 147, 5178–5186 (2006)
R. Ramachandran, O.M. Ocón-Grove, S.L. Metzger, Molecular cloning and tissue expression of chicken AdipoR1 and AdipoR2 complementary deoxyribonucleic acids. Domest. Anim. Endocrinol. 33, 19–31 (2007)
C. Chabrolle, L. Tosca, S. Crochet, S. Tesseraud, J. Dupont, Expression of adiponectin and its receptors (AdipoR1 and AdipoR2) in chicken ovary: potential role in ovarian steroidogenesis. Domest. Anim. Endocrinol. 33, 480–487 (2007)
A.E. Civitarese, C.P. Jenkinson, D. Richardson, M. Bajaj, K. Cusi, S. Kashyap, R. Berria, R. Belfort, R.A. DeFronzo, L.J. Mandarino, E. Ravussin, Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of Type 2 diabetes. Diabetologia 47, 816–820 (2004)
C. Hug, J. Wang, N.S. Ahmad, J.S. Bogan, T.-S. Tsao, H.F. Lodish, T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc. Natl Acad. Sci. USA 101, 10308–10313 (2004)
K. Asada, H. Yoshiji, R. Noguchi, Y. Ikenaka, M. Kitade, K. Kaji, J. Yoshii, K. Yanase, T. Namisaki, M. Yamazaki, T. Tsujimoto, T. Akahane, M. Uemura, H. Fukui, Crosstalk between high-molecular-weight adiponectin and T-cadherin during liver fibrosis development in rats. Int. J. Mol. Med. 20, 725–729 (2007)
M.S. Denzel, M.-C. Scimia, P.M. Zumstein, K. Walsh, P. Ruiz-Lozano, B. Ranscht, T-cadherin is critical for adiponectin-mediated cardioprotection in mice. J. Clin. Invest. 120, 4342–4352 (2010)
T. Takeuchi, Y. Adachi, Y. Ohtsuki, M. Furihata, Adiponectin receptors, with special focus on the role of the third receptor, T-cadherin, in vascular disease. Med. Mol. Morphol. 40, 115–120 (2007)
A.V. Andreeva, J. Han, M.A. Kutuzov, J. Profirovic, V.A. Tkachuk, T.A. Voyno-Yasenetskaya, T-cadherin modulates endothelial barrier function. J. Cell. Physiol. 223, 94–102 (2010)
S.B. Munro, O.W. Blaschuk, A comprehensive survey of the cadherins expressed in the testes of fetal, immature, and adult mice utilizing the polymerase chain reaction. Biol. Reprod. 55, 822–827 (1996)
X. Mao, C.K. Kikani, R.A. Riojas, P. Langlais, L. Wang, F.J. Ramos, Q. Fang, C.Y. Christ-Roberts, J.Y. Hong, R.-Y. Kim, F. Liu, L.Q. Dong, APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nat. Cell Biol. 8, 516–523 (2006)
M.J. Yoon, G.Y. Lee, J–.J. Chung, Y.H. Ahn, S.H. Hong, J.B. Kim, Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha. Diabetes 55, 2562–2570 (2006)
T. Yamauchi, J. Kamon, Y. Minokoshi, Y. Ito, H. Waki, S. Uchida, S. Yamashita, M. Noda, S. Kita, K. Ueki, K. Eto, Y. Akanuma, P. Froguel, F. Foufelle, P. Ferre, D. Carling, S. Kimura, R. Nagai, B.B. Kahn, T. Kadowaki, Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8, 1288–1295 (2002)
Y. Li, D.H. Ramdhan, H. Naito, N. Yamagishi, Y. Ito, Y. Hayashi, Y. Yanagiba, A. Okamura, H. Tamada, F.J. Gonzalez, T. Nakajima, Ammonium perfluorooctanoate may cause testosterone reduction by adversely affecting testis in relation to PPARα. Toxicol. Lett. 205, 265–272 (2011)
L. Brion, P.M. Maloberti, N.V. Gomez, C. Poderoso, A.B. Gorostizaga, M.M.M.S. Garcia, A.B. Acquier, M. Cooke, C.F. Mendez, E.J. Podesta, C. Paz, MAPK phosphatase-1 (MKP-1) expression is up-regulated by hCG/cAMP and modulates steroidogenesis in MA-10 Leydig cells. Endocrinology 152, 2665–2677 (2011)
S.W. Ahn, G.-T. Gang, S. Tadi, B. Nedumaran, Y.D. Kim, J.H. Park, G.R. Kweon, S.-H. Koo, K. Lee, R.-S. Ahn, Y.-H. Yim, C.-H. Lee, R.A. Harris, H.-S. Choi, Phosphoenolpyruvate carboxykinase and glucose-6-phosphatase are required for steroidogenesis in testicular Leydig cells. J. Biol. Chem. 287, 41875–41887 (2012)
L. Tosca, C. Chabrolle, J. Dupont, AMPK: a link between metabolism and reproduction? Médecine Sci. 24, 297–300 (2008)
L. Tosca, P. Froment, P. Solnais, P. Ferré, F. Foufelle, J. Dupont, Adenosine 5′-monophosphate-activated protein kinase regulates progesterone secretion in rat granulosa cells. Endocrinology 146, 4500–4513 (2005)
L. Tosca, C. Chabrolle, S. Uzbekova, J. Dupont, Effects of metformin on bovine granulosa cells steroidogenesis: possible involvement of adenosine 5′ monophosphate-activated protein kinase (AMPK). Biol. Reprod. 76, 368–378 (2007)
R. Ouedraogo, X. Wu, S.-Q. Xu, L. Fuchsel, H. Motoshima, K. Mahadev, K. Hough, R. Scalia, B.J. Goldstein, Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway. Diabetes 55, 1840–1846 (2006)
P. Park, H. Huang, M.R. McMullen, K. Bryan, L.E. Nagy, Activation of cyclic-AMP response element binding protein contributes to adiponectin-stimulated interleukin-10 expression in RAW 264.7 macrophages. J. Leukoc. Biol. 83, 1258–1266 (2008)
J.-P. Wen, W.-S. Lv, J. Yang, A.-F. Nie, X.-B. Cheng, Y. Yang, Y. Ge, X.-Y. Li, G. Ning, Globular adiponectin inhibits GnRH secretion from GT1-7 hypothalamic GnRH neurons by induction of hyperpolarization of membrane potential. Biochem. Biophys. Res. Commun. 371, 756–761 (2008)
N. Kubota, W. Yano, T. Kubota, T. Yamauchi, S. Itoh, H. Kumagai, H. Kozono, I. Takamoto, S. Okamoto, T. Shiuchi, R. Suzuki, H. Satoh, A. Tsuchida, M. Moroi, K. Sugi, T. Noda, H. Ebinuma, Y. Ueta, T. Kondo, E. Araki, O. Ezaki, R. Nagai, K. Tobe, Y. Terauchi, K. Ueki, Y. Minokoshi, T. Kadowaki, Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab. 6, 55–68 (2007)
A. Psilopanagioti, H. Papadaki, E.F. Kranioti, T.K. Alexandrides, J.N. Varakis, Expression of adiponectin and adiponectin receptors in human pituitary gland and brain. Neuroendocrinology 89, 38–47 (2009)
M. Mitchell, D.T. Armstrong, R.L. Robker, R.J. Norman, Adipokines: implications for female fertility and obesity. Reprod. Camb. Engl. 130, 583–597 (2005)
T.P. Combs, U.B. Pajvani, A.H. Berg, Y. Lin, L.A. Jelicks, M. Laplante, A.R. Nawrocki, M.W. Rajala, A.F. Parlow, L. Cheeseboro, Y–.Y. Ding, R.G. Russell, D. Lindemann, A. Hartley, G.R.C. Baker, S. Obici, Y. Deshaies, M. Ludgate, L. Rossetti, P.E. Scherer, A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology 145, 367–383 (2004)
N. Kubota, Y. Terauchi, T. Yamauchi, T. Kubota, M. Moroi, J. Matsui, K. Eto, T. Yamashita, J. Kamon, H. Satoh, W. Yano, P. Froguel, R. Nagai, S. Kimura, T. Kadowaki, T. Noda, Disruption of adiponectin causes insulin resistance and neointimal formation. J. Biol. Chem. 277, 25863–25866 (2002)
K. Ma, A. Cabrero, P.K. Saha, H. Kojima, L. Li, B.H.-J. Chang, A. Paul, L. Chan, Increased beta-oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin. J. Biol. Chem. 277, 34658–34661 (2002)
N. Maeda, I. Shimomura, K. Kishida, H. Nishizawa, M. Matsuda, H. Nagaretani, N. Furuyama, H. Kondo, M. Takahashi, Y. Arita, R. Komuro, N. Ouchi, S. Kihara, Y. Tochino, K. Okutomi, M. Horie, S. Takeda, T. Aoyama, T. Funahashi, Y. Matsuzawa, Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 8, 731–737 (2002)
W. Pan, H. Tu, A.J. Kastin, Differential BBB interactions of three ingestive peptides: obestatin, ghrelin, and adiponectin. Peptides 27, 911–916 (2006)
J. Spranger, S. Verma, I. Göhring, T. Bobbert, J. Seifert, A.L. Sindler, A. Pfeiffer, S.M. Hileman, M. Tschöp, W.A. Banks, Adiponectin does not cross the blood–brain barrier but modifies cytokine expression of brain endothelial cells. Diabetes 55, 141–147 (2006)
Y. Qi, N. Takahashi, S.M. Hileman, H.R. Patel, A.H. Berg, U.B. Pajvani, P.E. Scherer, R.S. Ahima, Adiponectin acts in the brain to decrease body weight. Nat. Med. 10, 524–529 (2004)
C.M. Kusminski, P.G. McTernan, T. Schraw, K. Kos, J.P. O’Hare, R. Ahima, S. Kumar, P.E. Scherer, Adiponectin complexes in human cerebrospinal fluid: distinct complex distribution from serum. Diabetologia 50, 634–642 (2007)
X.-B. Cheng, J.-P. Wen, J. Yang, Y. Yang, G. Ning, X.-Y. Li, GnRH secretion is inhibited by adiponectin through activation of AMP-activated protein kinase and extracellular signal-regulated kinase. Endocrine 39, 6–12 (2011)
J.-P. Wen, C. Liu, W.-K. Bi, Y.-T. Hu, Q. Chen, H. Huang, J.-X. Liang, L.-T. Li, L.-X. Lin, G. Chen, Adiponectin inhibits KISS1 gene transcription through AMPK and specificity protein-1 in the hypothalamic GT1-7 neurons. J. Endocrinol. 214, 177–189 (2012)
M. Lu, Q. Tang, J.M. Olefsky, P.L. Mellon, N.J.G. Webster, Adiponectin activates adenosine monophosphate-activated protein kinase and decreases luteinizing hormone secretion in LbetaT2 gonadotropes. Mol. Endocrinol. Baltim. Md. 22, 760–771 (2008)
O.M. Ocón-Grove, S.M. Krzysik-Walker, S.R. Maddineni, G.L. Hendricks 3rd, R. Ramachandran, Adiponectin and its receptors are expressed in the chicken testis: influence of sexual maturation on testicular ADIPOR1 and ADIPOR2 mRNA abundance. Reprod. Camb. Engl. 136, 627–638 (2008)
A. Pfaehler, M.K. Nanjappa, E.S. Coleman, M. Mansour, D. Wanders, E.P. Plaisance, R.L. Judd, B.T. Akingbemi, Regulation of adiponectin secretion by soy isoflavones has implication for endocrine function of the testis. Toxicol. Lett. 209, 78–85 (2012)
J.E. Caminos, R. Nogueiras, R. Gallego, S. Bravo, S. Tovar, T. García-Caballero, F.F. Casanueva, C. Diéguez, Expression and regulation of adiponectin and receptor in human and rat placenta. J. Clin. Endocrinol. Metab. 90, 4276–4286 (2005)
P. Li, F. Sun, H.-M. Cao, Q.-Y. Ma, C.-M. Pan, J.-H. Ma, X.-N. Zhang, H. Jiang, H.-D. Song, M.-D. Chen, Expression of adiponectin receptors in mouse adrenal glands and the adrenocortical Y-1 cell line: adiponectin regulates steroidogenesis. Biochem. Biophys. Res. Commun. 390, 1208–1213 (2009)
K.A. Toulis, D.G. Goulis, D. Farmakiotis, N.A. Georgopoulos, I. Katsikis, B.C. Tarlatzis, I. Papadimas, D. Panidis, Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Hum. Reprod. Updat. 15, 297–307 (2009)
M. Otani, M. Kogo, S. Furukawa, S. Wakisaka, T. Maeda, The adiponectin paralog C1q/TNF-related protein 3 (CTRP3) stimulates testosterone production through the cAMP/PKA signaling pathway. Cytokine 58, 238–244 (2012)
D.V. Lagaly, P.Y. Aad, J.A. Grado-Ahuir, L.B. Hulsey, L.J. Spicer, Role of adiponectin in regulating ovarian theca and granulosa cell function. Mol. Cell. Endocrinol. 284, 38–45 (2008)
C. Chabrolle, L. Tosca, C. Ramé, P. Lecomte, D. Royère, J. Dupont, Adiponectin increases insulin-like growth factor I-induced progesterone and estradiol secretion in human granulosa cells. Fertil. Steril. 92, 1988–1996 (2009)
J.S. Richards, Z. Liu, T. Kawai, K. Tabata, H. Watanabe, D. Suresh, F.-T. Kuo, M.D. Pisarska, M. Shimada, Adiponectin and its receptors modulate granulosa cell and cumulus cell functions, fertility, and early embryo development in the mouse and human. Fertil. Steril. 98, 471–479 (2012)
M.-C.M. Shih, Y.-N. Chiu, M.-C. Hu, I.-C. Guo, B. Chung, Regulation of steroid production: analysis of Cyp11a1 promoter. Mol. Cell. Endocrinol. 336, 80–84 (2011)
P. Pena, A.T. Reutens, C. Albanese, M. D’Amico, G. Watanabe, A. Donner, I.W. Shu, T. Williams, R.G. Pestell, Activator protein-2 mediates transcriptional activation of the CYP11A1 gene by interaction with Sp1 rather than binding to DNA. Mol. Endocrinol. Baltim. Md. 13, 1402–1416 (1999)
T. Sugawara, M. Saito, S. Fujimoto, Sp1 and SF-1 interact and cooperate in the regulation of human steroidogenic acute regulatory protein gene expression. Endocrinology 141, 2895–2903 (2000)
K. Momoi, M.R. Waterman, E.R. Simpson, U.M. Zanger, 3′,5′-Cyclic adenosine monophosphate-dependent transcription of the CYP11A (cholesterol side chain cleavage cytochrome P450) gene involves a DNA response element containing a putative binding site for transcription factor Sp1. Mol. Endocrinol. Baltim. Md. 6, 1682–1690 (1992)
H. Lin, C.-H. Yu, C.-Y. Jen, C.-F. Cheng, Y. Chou, C–.C. Chang, S.-H. Juan, Adiponectin-mediated heme oxygenase-1 induction protects against iron-induced liver injury via a PPARα dependent mechanism. Am. J. Pathol. 177, 1697–1709 (2010)
L.-F. Liu, W.-J. Shen, Z.H. Zhang, L.J. Wang, F.B. Kraemer, Adipocytes decrease Runx2 expression in osteoblastic cells: roles of PPARγ and adiponectin. J. Cell. Physiol. 225, 837–845 (2010)
F.-P. Lee, C.-Y. Jen, C–.C. Chang, Y. Chou, H. Lin, C.-M. Chou, S.-H. Juan, Mechanisms of adiponectin-mediated COX-2 induction and protection against iron injury in mouse hepatocytes. J. Cell. Physiol. 224, 837–847 (2010)
L. Wu, B. Xu, W. Fan, X. Zhu, G. Wang, A. Zhang, Adiponectin protects Leydig cells against proinflammatory cytokines by suppressing the nuclear factor-κB signaling pathway. FEBS J. 280, 3920–3927 (2013)
C.Y. Hong, J.H. Park, R.S. Ahn, S.Y. Im, H.-S. Choi, J. Soh, S.H. Mellon, K. Lee, Molecular mechanism of suppression of testicular steroidogenesis by proinflammatory cytokine tumor necrosis factor alpha. Mol. Cell. Biol. 24, 2593–2604 (2004)
C.D.B. Fernandez, F.F. Bellentani, G.S.A. Fernandes, J.E. Perobelli, A.P.A. Favareto, A.F. Nascimento, A.C. Cicogna, W.D.G. Kempinas, Diet-induced obesity in rats leads to a decrease in sperm motility. Reprod. Biol. Endocrinol. 9, 32 (2011)
F. Erdemir, D. Atilgan, F. Markoc, O. Boztepe, B. Suha-Parlaktas, S. Sahin, The effect of diet induced obesity on testicular tissue and serum oxidative stress parameters. Actas Urol. Españolas. 36, 153–159 (2012)
Thomas, S., Kratzsch, D., Schaab, M., Scholz, M., Grunewald, S., Thiery, J., Paasch, U., Kratzsch, J.: Seminal plasma adipokine levels are correlated with functional characteristics of spermatozoa. Fertil. Steril. 99, 1256–1263 (2013)
Kasimanickam, V.R., Kasimanickam, R.K., Kastelic, J.P., Stevenson, J.S.: Associations of adiponectin and fertility estimates in Holstein bulls. Theriogenology 79, 766–777 (2013)
F. Rahmanifar, M.R. Tabandeh, Adiponectin and its receptors gene expression in the reproductive tract of ram. Small Rumin. Res. 105, 263–267 (2012)
M.H. Dai, T. Xia, G.D. Zhang, X.D. Chen, L. Gan, S.Q. Feng, H. Qiu, Y. Peng, Z.Q. Yang, Cloning, expression and chromosome localization of porcine adiponectin and adiponectin receptors genes. Domest. Anim. Endocrinol. 30, 117–125 (2006)
M. Archanco, J. Gómez-Ambrosi, M. Tena-Sempere, G. Frühbeck, M.A. Burrell, Expression of leptin and adiponectin in the rat oviduct. J. Histochem. Cytochem. Off. J. Histochem. Soc. 55, 1027–1037 (2007)
E.R.M. Hofny, M.E. Ali, H.Z. Abdel-Hafez, E.E.-D. Kamal, E.E. Mohamed, H.G. Abd El-Azeem, T. Mostafa, Semen parameters and hormonal profile in obese fertile and infertile males. Fertil. Steril. 94, 581–584 (2010)
A. Taylor, ABC of subfertility: extent of the problem. BMJ 327, 434–436 (2003)
R. Pasquali, L. Patton, A. Gambineri, Obesity and infertility. Curr. Opin. Endocrinol. Diabetes Obes. 14, 482–487 (2007)
R. Ramachandran, S. Maddineni, O. Ocón-Grove, G. Hendricks 3rd, R. Vasilatos-Younken, J.A. Hadley, Expression of adiponectin and its receptors in avian species. Gen. Comp. Endocrinol. 190, 88–95 (2013)
C. Lee, C.-H. Huang, LASAGNA-Search: an integrated web tool for transcription factor binding site search and visualization. Biotechniques 54, 141–153 (2013)
E. Wingender, P. Dietze, H. Karas, R. Knüppel, TRANSFAC: a database on transcription factors and their DNA binding sites. Nucl. Acids Res. 24, 238–241 (1996)
Acknowledgments
Current work was funded by the New Brunswick Health Research Foundation (NBHRF), Canada.
Disclosure
The author declares that there is no conflict of interest that would prejudice his impartiality.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Martin, L.J. Implications of adiponectin in linking metabolism to testicular function. Endocrine 46, 16–28 (2014). https://doi.org/10.1007/s12020-013-0102-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-013-0102-0